Immunomodulation by conditioning: recent developments.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  International Journal of Neuroscience

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3109/00207459309000607PMID 8407149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anaphylactic shock in neuropsychoimmunological research.

  1992cited by this paper
• Modulation of immune status by a conditioned aversive stimulus: evidence for the involvement of endogenous opioids.

  1992cited by this paper
• Conditioned stress responses by pregnant and/or lactating mice reduce immune responses of their offspring after weaning.

  1992cited by this paper
• Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity.

  1992cited by this paper
• Suppression of the development of adjuvant arthritis by a conditioned aversive stimulus.

  1992cited by this paper
• Conditioned immunosuppression of a murine delayed type hypersensitivity response: dissociation from corticosterone elevation.

  1991cited by this paper
• Behavioral conditioning prolongs heart allograft survival in rats.

  1991cited by this paper
• In vivo enhancement of NK cell activity with met-enkephalin and glycyl-glutamine: their possible role in the conditioned response.

  1991cited by this paper
• Enkephalins and immune inflammatory reactions.

  1991cited by this paper
• Enkephalins and immune inflammatory reactions.

  1991cited by this paper
• Pharmacological manipulation of immune alterations induced by an aversive conditioned stimulus: evidence for a beta-adrenergic receptor-mediated Pavlovian conditioning process.

  1991cited by this paper
• A behavioral augmentation of natural immunity: odor specificity supports a Pavlovian conditioning model.

  1991cited by this paper
• Pharmacological Manipulation of Immune Alterations Induced by an Aversive Conditioned Stimulus: Evidence for a β-Adrenergic Receptor-Mediated Pavlovian Conditioning Process

  1991cited by this paper
• Conditioned cyclosporine effects but not conditioned taste aversion in immunized rats.

  1990cited by this paper
• The influence of dexamethasone on behaviorally conditioned immunomodulation and plasma corticosterone.

  1990cited by this paper
• The Pavlovian conditioning of IL-1-induced glucocorticoid secretion.

  1990cited by this paper
• Naltrexone blocks the expression of the conditioned elevation of natural killer cell activity in BALB/c mice.

  1989cited by this paper
• Neuroleptic and anti-depressant drug treatment abolishes conditioned immunosuppression in mice.

  1989cited by this paper
• Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II.

  1989cited by this paper
• Conditional immunomodulation following training with cyclophosphamide.

  1989cited by this paper
• Peripheral versus intracerebroventricular administration of quaternary naltrexone and the enhancement of Pavlovian conditioning.

  1988cited by this paper
• Anaphylactic shock-induced conditioned taste aversion. II. Correlation between taste aversion and indicators of anaphylactic shock.

  1988cited by this paper
• Pavlovian conditioning of shock-induced suppression of lymphocyte reactivity: acquisition, extinction, and preexposure effects.

  1988cited by this paper
• Anaphylactic shock-induced conditioned taste aversion. I. Demonstration of the phenomenon by means of three modes of CS-US presentation.

  1988cited by this paper
• Conditioned compensatory responses elicited by environmental signals for cyclophosphamide-induced suppression of antibody production in mice

  1988cited by this paper
• Behaviorally conditioned suppression of mitogen-induced proliferation and immunoglobulin production: effect of time span between conditioning and reexposure to the conditioning stimulus.

  1988cited by this paper
• Conditioned augmentation of natural killer cell activity. Independence from nociceptive effects and dependence on interferon-beta.

  1988cited by this paper
• Conditioned Immunosuppression. A New Methodological Approach

  1987cited by this paper
• Cortisol and Behaviorally Conditioned Histamine Release a

  1987cited by this paper
• Conditioned Suppression of Plaque‐Forming Cell Responses with Cyclophosphamide. The Role of Taste Aversion a

  1987cited by this paper
• Classically Conditioned Effects of Cyclophosphamide on White Blood Cell Counts in Rats

  1987cited by this paper
• Conditioned Effects of Cyclophosphamide. Enhancement of Delayed‐Type Hypersensitivity in the Mouse a

  1987cited by this paper
• Conditioned enhancement of natural killer cell activity, but not interferon, with camphor or saccharin‐Licl conditioned stimulus

  1987cited by this paper
• Conditioned immunosuppression in young versus aged mice: differences in cells and responses to environmental stimuli lead to altered conditioning in aged animals.

  1987cited by this paper
• Analysis of lymphocytes in, and host environment of, mice showing conditioned immunosuppression to cyclophosphamide.

  1987cited by this paper
• Behaviourally conditioned modification of T cell subset ratios in rats.

  1987cited by this paper
• Conditioned tolerance to drug-induced (poly I:C) natural killer cell activation: effects of drug-dosage and context-specificity parameters.

  1987cited by this paper
• Regulation of Natural Immunity (NK Activity) by Conditioning a

  1987cited by this paper
• Behaviorally Conditioned Histamine Release. Prior Stress and Conditionability and Extinction of the Response a

  1987cited by this paper
• Influence of Conditioned Natural Immunity on Tumor Growth a

  1987cited by this paper
• Conditioned Taste Aversion in Rats Subjected to Anaphylactic Shock a

  1987cited by this paper
• Modulation of in vivo immune responses by enkephalins.

  1986cited by this paper
• Some parameters of conditioned immunosuppression: species difference and CS-US delay.

  1986cited by this paper
• Tolerance to drug-induced (poly I:C) natural killer cell activation: congruence with a Pavlovian conditioning model.

  1986cited by this paper
• Regeneration of entire skeletal muscles.

  1986cited by this paper
• Leu-enkephalin actions on avoidance conditioning are mediated by a peripheral opioid mechanism.

  1985cited by this paper
• Conditioned taste aversion suppresses induction of delayed-type hypersensitivity immune reactions.

  1985cited by this paper
• Neural and environmental influences on neoplasia and conditioning of NK activity.

  1985cited by this paper
• Morphine tolerance as habituation.

  1985cited by this paper
• Cimetidine reverses tumor growth enhancement of plasmacytoma tumors in mice demonstrating conditioned immunosuppression.

  1985cited by this paper
• The use of quaternary narcotic antagonists in opiate research.

  1985cited by this paper
• Acquisition and extinction of conditioned suppression of a graft-vs-host response in the rat.

  1984cited by this paper
• Learned histamine release.

  1984cited by this paper
• Influence of conditioned psychological stress on immunological recovery in mice exposed to low-dose X irradiation.

  1984cited by this paper
• Classical Conditioning, Drug Tolerance, and Drug Dependence

  1983cited by this paper
• Classically conditioned enhancement of antibody production

  1983cited by this paper
• Pavlovian conditioning of immunosuppression modifies adjuvant arthritis in rats.

  1983cited by this paper
• Behaviorally conditioned suppression of the immune response by antilymphocyte serum.

  1983cited by this paper
• Conditioning of drug-induced physiological responses.

  1982cited by this paper
• Suppression of experimental allergic thyroiditis in rats treated with lithium chloride.

  1982cited by this paper
• Effect of Cyclophosphamide on Immunological Control Mechanisms

  1982cited by this paper
• Conditioned immune response associated with allogeneic skin grafts in mice.

  1982cited by this paper
• Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus.

  1982cited by this paper
• Cyclosporin A – Usefulness, Risks and Mechanism of Action

  1982cited by this paper
• The Use of Cyclosporin A Immunosuppression in Organ Grafting

  1982cited by this paper
• Conditioned suppression of humoral immunity in the rat.

  1982cited by this paper
• Negative immune deviation induced by lithium cation

  1980cited by this paper
• Augmentation of mouse natural killer cell activity by interferon and interferon inducers.

  1979cited by this paper
• Adrenal involvement in conditioned immunosuppression.

  1979cited by this paper
• Conditioned suppression of a thymus-independent antibody response.

  1979cited by this paper
• Cation-induced immunosuppression: the effect of lithium or Arthus reactivity, delayed hypersensitivity and antibody production in the rat.

  1979cited by this paper
• Enhanced NK cell activity in mice injected with interferon and interferon inducers

  1978cited by this paper
• Effects of taste aversion conditioning on the primary antibody response to sheep red blood cells and Brucella abortus in the albino rat.

  1978cited by this paper
• Effects of cyclophosphamide on macrophage numbers, functions and progenitor cells.

  1977cited by this paper
• The effect of cyclophosphamide on suppressor cells in guinea pigs.

  1977cited by this paper
• Plasma corticosterone levels during recovery from LiCl produced taste aversions.

  1976cited by this paper
• Conditioned adrenocortical steroid elevations in the rat.

  1976cited by this paper
• Behaviorally conditioned immunosuppression: replication of a recent study.

  1976cited by this paper
• Letter: Behaviorially conditioned immunosuppression.

  1974cited by this paper
• Behaviorally Conditioned Immunosuppression

  1974cited by this paper
• Delayed‐Type Hypersensitivity in the Mouse

  1972cited by this paper
• Selective depletion of lymphoid tissue by cyclophosphamide.

  1972cited by this paper
• Proportional increase in the theta carrying lymphocytes in peripheral lymphoid tissue following treatment with cyclophosphamide.

  1972cited by this paper
• THE THYMUS AND RECOVERY FROM CYCLOPHOSPHAMIDE-INDUCED TOLERANCE TO SHEEP ERYTHROCYTES

  1968cited by this paper
• Humoral Mediation of Radiation-Induced Motivation in Parabiont Rats

  1965cited by this paper
• The problem of a conditioned reflex regulation of immunobiological reactions

  1961cited by this paper
• [The problem of a conditioned reflex regulation of immunobiological reactions].

  1961cited by this paper
• Learned Asthma in the Guinea Pig

  1958cited by this paper
• Conditioned aversion to saccharin resulting from exposure to gamma radiation.

  1955cited by this paper

• Placebo

  2014cites this paper
• Learned placebo responses in neuroendocrine and immune functions.

  2014cites this paper
• The learned immune response: Pavlov and beyond.

  2010cites this paper
• CHAPTER 30 – Behaviorally Conditioned Enhancement of Immune Responses

  2007cites this paper
• Named Series: Brain Mechanisms of Placebo Expectations and associations that heal: Immunomodulatory placebo eVects and its neurobiology

  2006cites this paper
• The involvement of glutamate in recall of the conditioned NK cell response.

  2001cites this paper
• Nk Cell and Ctl Activities Can Be Raised Via Conditioning of the Cns with Unrelated Unconditioned Stimuli: Neuroimmunomodulation

  2000cites this paper
• Psychoneuroendocrine immunology: perception of stress can alter body temperature and natural killer cell activity.

  1999cites this paper
• Psychoneuroendocrine immunology: site of recognition, learning and memory in the immune system and the brain.

  1997cites this paper
• Conditioning of body temperature and natural killer cell activity with arecoline, a muscarinic cholinergic agonist.

  1996cites this paper
• The use of conditioning to probe for CNS pathways that regulate fever and NK cell activity.

  1996cites this paper
• Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity.

  1995cites this paper